Author Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
作者信息
Rahman Alvi A, Renoux Christel
机构信息
(Montreal).
出版信息
Neurology. 2023 Oct 17;101(16):729. doi: 10.1212/WNL.0000000000207890.
Abstract
摘要
相似文献
1
Author Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2023 Oct 17;101(16):729. doi: 10.1212/WNL.0000000000207890.
2
Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2023 Oct 17;101(16):728-729. doi: 10.1212/WNL.0000000000207889.
3
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
Am J Med. 2019 May;132(5):596-604.e11. doi: 10.1016/j.amjmed.2018.12.023. Epub 2019 Jan 9.
4
Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2627-2631. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.036. Epub 2018 Jun 30.
5
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2079-2084. doi: 10.2215/CJN.02680316. Epub 2016 Oct 25.
6
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
J Am Heart Assoc. 2018 Apr 13;7(8):e008643. doi: 10.1161/JAHA.118.008643.
7
Author Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2024 Feb 27;102(4):e209238. doi: 10.1212/WNL.0000000000209238. Epub 2024 Jan 24.
8
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation.
J Am Heart Assoc. 2019 Mar 5;8(5):e011112. doi: 10.1161/JAHA.118.011112.
9
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
Stroke. 2017 Nov;48(11):3040-3048. doi: 10.1161/STROKEAHA.117.018773. Epub 2017 Oct 3.
10
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
CMAJ Open. 2020 Dec 18;8(4):E877-E886. doi: 10.9778/cmajo.20200055. Print 2020 Oct-Dec.
本文引用的文献
1
Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2023 Mar 21;100(12):e1309-e1320. doi: 10.1212/WNL.0000000000206748. Epub 2022 Dec 29.
Zotero 插件